Veterinary Medicines

Avishield IBD plus, lyophilisate for use in drinking water, for chickens

Authorised
  • Infectious bursal disease virus, strain G6, Live
Download as PDF

Product identification

Medicine name:
Avishield IBD plus, lyophilisate for use in drinking water, for chickens
Avishield IBD Plus, lyofilisaat voor gebruik in drinkwater, voor kippen
Avishield IBD Plus, lyophilisat pour administration dans l'eau de boisson, pour poulets
Avishield IBD Plus, Lyophilisat zum Eingeben über das Trinkwasser, für Hühner
Active substance:
  • Infectious bursal disease virus, strain G6, Live
Target species:
  • Chicken
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain G6, Live
    1.90
    unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • All relevant tissues
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Cardboard box with 10 vials of 5,000 doses of vaccine. Colourless glass vials (type I) filled into 10 ml (5000 doses), which are closed with bromobutyl rubber stoppers and sealed with aluminium caps.
  • Cardboard box with 10 vials of 2,500 doses of vaccine. Colourless glass vials (type I) filled into 10 ml (2500 doses), which are closed with bromobutyl rubber stoppers and sealed with aluminium caps.
  • Cardboard box with 10 vials of 1,000 doses of vaccine. Colourless glass vials (type I) filled into 4 ml (1000 doses), which are closed with bromobutyl rubber stoppers and sealed with aluminium caps.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Genera d.d.
Marketing authorisation date:
This information is not available for this product.
Manufacturing sites for batch release:
  • Genera d.d.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V562951
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0311/001
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Czechia
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download
German (PDF)
Published on: 22/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."